Report
Maissa Keskes ...
  • Stephane Houri

Cicor Technologies Ltd : Vers un nouveau champion européen dans l’EMS

Cicor, groupe suisse spécialisé dans les services de fabrication électronique (EMS), devrait bénéficier de la croissance de ses marchés cibles (l’aéronautique & défense, l’industrie et le médical), et de la poursuite de sa stratégie de croissance externe, entamée en 2021 (TMVA 25/28e BPA 25%). Le rachat à finaliser de TT Electronics doublera quasiment son périmètre et constituerait un catalyseur de revalorisation du titre (OC porté à 255 CHF). Initiation à Surperformance avec OC à 227 CHF.
Underlying
Cicorel Holding S.A.

Cicor Technologies Ltd is a Swiss company engaged in the electrical engineering and electronics sector. The Company operated though four divisions: Cicor Printed Circuit Boards; Cicor Microelectronics; Cicor Electronic Solutions, and Asia division. The Cicor Printed Circuit Boards (PCB) division develops and produces printed circuit boards with the usage of high density interconnects (HDI's) and reel-to-reel technology. The Cicor Microelectronics division offers a range of microelectronic manufacturing from various thick and thin film coating technologies through micro assembly and up to delivery of tested and qualified electronic components. The Cicor Electronic Solutions division provides a range of production options for PCB assembly, system assembly, box-building and switch-box construction, cable assembly, tool making and injection molding. The Asia division focuses on the provision of the Company's technology to the Asian market.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Maissa Keskes

Stephane Houri

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch